Maximus (MMS) is back in focus after quarterly earnings showed lower sales alongside higher profitability, supported by automation and AI driven efficiencies. Management kept revenue guidance unchanged and lifted adjusted EPS guidance for fiscal 2026.

The earnings update and higher adjusted EPS guidance have not yet shifted sentiment, with the share price down 14.5% over the past month and the 1 year total shareholder return also in decline. This suggests that momentum is still fading.

If you are looking beyond Maximus and want ideas tied to automation and AI themes, it could be worth checking out 62 profitable AI stocks that aren't just burning cash

With earnings holding up better than the share price, and the stock trading well below analyst targets and some intrinsic value estimates, you have to ask: is Maximus now undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 46% Undervalued

Maximus last closed at $59.36, while the most followed narrative anchors on a fair value of $110 per share, built using an 8.27% discount rate.

The company's ongoing investments in digital, workflow automation, and AI (notably for complex health and claims processing), along with recent inorganic growth and expanded pipeline in federal and state markets, are laying the groundwork for sustainable earnings growth above the rate of revenue growth, as evidenced by recent margin performance and forward guidance.

The fair value hinges on moderate top line growth, higher margins, and a richer future earnings multiple, all combined into one detailed cash flow path.

Result: Fair Value of $110 (UNDERVALUED)

However, you still need to factor in that heavy reliance on large government contracts, along with potential budget or legislative shifts, could quickly unsettle revenue and margin expectations.

Next Steps

Given the mixed mood in this story, with risks and rewards both in play, it makes sense to look at the underlying data yourself and move quickly to shape your own view. You can start with 5 key rewards and 1 important warning sign

Looking for more investment ideas?

If you stop with just one stock, you could miss opportunities that better fit your goals, so use the tools available and keep your watchlist evolving.

• Target potential mispricing by scanning a curated set of 50 high quality undervalued stocks that pair quality fundamentals with appealing valuations.
• Strengthen portfolio resilience by focusing on 66 resilient stocks with low risk scores that score well on stability and downside protection.
• Get ahead of the crowd by reviewing a screener containing 22 high quality undiscovered gems before they attract wider attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.